Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen: = Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis Electronic eBook |
| Language: | German |
| Published: |
Berlin
2024
|
| Subjects: | |
| Online Access: | Volltext Volltext |
| Physical Description: | 1 Online-Ressource (viii, 139 Seiten) Illustrationen, Diagramme |
| DOI: | 10.17169/refubium-41640 |
Staff View
MARC
| LEADER | 00000nmm a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV049638785 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 006 | a m||| 00||| | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 240408s2024 |||| o||u| ||||||ger d | ||
| 024 | 7 | |a 10.17169/refubium-41640 |2 doi | |
| 024 | 7 | |a urn:nbn:de:kobv:188-refubium-41919-7 |2 urn | |
| 035 | |a (DE-599)BVBBV049638785 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a ger | |
| 049 | |a DE-578 | ||
| 084 | |a 610 |2 FUB | ||
| 100 | 1 | |a Göhringer, Nils |d 1995- |e Verfasser |0 (DE-588)1325496553 |4 aut | |
| 245 | 1 | 0 | |a Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen |b = Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas |c vorgelegt von Nils Göhringer |
| 246 | 1 | 1 | |a Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas |
| 264 | 1 | |a Berlin |c 2024 | |
| 300 | |a 1 Online-Ressource (viii, 139 Seiten) |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 502 | |b Dissertation |c Charité - Universitätsmedizin Berlin |d 2024 | ||
| 505 | 8 | |a enthält außerdem 3 Sonderdrucke aus verschiedenen Zeitschriften | |
| 650 | 4 | |a anti-angiogenesis | |
| 650 | 4 | |a anticancer drugs | |
| 650 | 4 | |a chimeric inhibitor | |
| 650 | 4 | |a epidermal growth factor (EGFR) | |
| 650 | 4 | |a hepatocellular carcinoma (HCC) | |
| 650 | 4 | |a histone deacetylase (HDAC) | |
| 650 | 4 | |a histone deacetylase inhibitor (HDACi) | |
| 650 | 4 | |a prostate cancer (PCa) | |
| 650 | 4 | |a solid cancer | |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |w (DE-604)BV049638788 |
| 856 | 4 | 0 | |u https://refubium.fu-berlin.de/handle/fub188/41919 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.17169/refubium-41640 |x Resolving-System |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034982448 | ||
Record in the Search Index
| _version_ | 1804186546215059456 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Göhringer, Nils 1995- |
| author_GND | (DE-588)1325496553 |
| author_facet | Göhringer, Nils 1995- |
| author_role | aut |
| author_sort | Göhringer, Nils 1995- |
| author_variant | n g ng |
| building | Verbundindex |
| bvnumber | BV049638785 |
| collection | ebook |
| contents | enthält außerdem 3 Sonderdrucke aus verschiedenen Zeitschriften |
| ctrlnum | (DE-599)BVBBV049638785 |
| doi_str_mv | 10.17169/refubium-41640 |
| format | Thesis Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02054nmm a2200481 c 4500</leader><controlfield tag="001">BV049638785</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="006">a m||| 00||| </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">240408s2024 |||| o||u| ||||||ger d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.17169/refubium-41640</subfield><subfield code="2">doi</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:kobv:188-refubium-41919-7</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049638785</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-578</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">FUB</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Göhringer, Nils</subfield><subfield code="d">1995-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1325496553</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen</subfield><subfield code="b">= Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas</subfield><subfield code="c">vorgelegt von Nils Göhringer</subfield></datafield><datafield tag="246" ind1="1" ind2="1"><subfield code="a">Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin</subfield><subfield code="c">2024</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (viii, 139 Seiten)</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Charité - Universitätsmedizin Berlin</subfield><subfield code="d">2024</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">enthält außerdem 3 Sonderdrucke aus verschiedenen Zeitschriften</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anti-angiogenesis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anticancer drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">chimeric inhibitor</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">epidermal growth factor (EGFR)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hepatocellular carcinoma (HCC)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">histone deacetylase (HDAC)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">histone deacetylase inhibitor (HDACi)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">prostate cancer (PCa)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">solid cancer</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="w">(DE-604)BV049638788</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://refubium.fu-berlin.de/handle/fub188/41919</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.17169/refubium-41640</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034982448</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV049638785 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T23:39:15Z |
| indexdate | 2024-07-10T10:12:51Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034982448 |
| open_access_boolean | 1 |
| owner | DE-578 |
| owner_facet | DE-578 |
| physical | 1 Online-Ressource (viii, 139 Seiten) Illustrationen, Diagramme |
| psigel | ebook |
| publishDate | 2024 |
| publishDateSearch | 2024 |
| publishDateSort | 2024 |
| record_format | marc |
| spelling | Göhringer, Nils 1995- Verfasser (DE-588)1325496553 aut Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen = Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas vorgelegt von Nils Göhringer Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas Berlin 2024 1 Online-Ressource (viii, 139 Seiten) Illustrationen, Diagramme txt rdacontent c rdamedia cr rdacarrier Dissertation Charité - Universitätsmedizin Berlin 2024 enthält außerdem 3 Sonderdrucke aus verschiedenen Zeitschriften anti-angiogenesis anticancer drugs chimeric inhibitor epidermal growth factor (EGFR) hepatocellular carcinoma (HCC) histone deacetylase (HDAC) histone deacetylase inhibitor (HDACi) prostate cancer (PCa) solid cancer (DE-588)4113937-9 Hochschulschrift gnd-content Erscheint auch als Druck-Ausgabe (DE-604)BV049638788 https://refubium.fu-berlin.de/handle/fub188/41919 Resolving-System kostenfrei Volltext https://doi.org/10.17169/refubium-41640 Resolving-System kostenfrei Volltext |
| spellingShingle | Göhringer, Nils 1995- Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen = Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas enthält außerdem 3 Sonderdrucke aus verschiedenen Zeitschriften anti-angiogenesis anticancer drugs chimeric inhibitor epidermal growth factor (EGFR) hepatocellular carcinoma (HCC) histone deacetylase (HDAC) histone deacetylase inhibitor (HDACi) prostate cancer (PCa) solid cancer |
| subject_GND | (DE-588)4113937-9 |
| title | Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen = Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas |
| title_alt | Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas |
| title_auth | Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen = Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas |
| title_exact_search | Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen = Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas |
| title_exact_search_txtP | Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen = Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas |
| title_full | Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen = Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas vorgelegt von Nils Göhringer |
| title_fullStr | Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen = Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas vorgelegt von Nils Göhringer |
| title_full_unstemmed | Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen = Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas vorgelegt von Nils Göhringer |
| title_short | Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen |
| title_sort | untersuchungen zur antineoplastischen wirkung neuartiger hdac inhibitoren bei prostata und hepatozellularen karzinomen studies on the antineoplastic effect of novel hdac inhibitors in prostate and hepatocellular carcinomas |
| title_sub | = Studies on the antineoplastic effect of novel HDAC inhibitors in prostate and hepatocellular carcinomas |
| topic | anti-angiogenesis anticancer drugs chimeric inhibitor epidermal growth factor (EGFR) hepatocellular carcinoma (HCC) histone deacetylase (HDAC) histone deacetylase inhibitor (HDACi) prostate cancer (PCa) solid cancer |
| topic_facet | anti-angiogenesis anticancer drugs chimeric inhibitor epidermal growth factor (EGFR) hepatocellular carcinoma (HCC) histone deacetylase (HDAC) histone deacetylase inhibitor (HDACi) prostate cancer (PCa) solid cancer Hochschulschrift |
| url | https://refubium.fu-berlin.de/handle/fub188/41919 https://doi.org/10.17169/refubium-41640 |
| work_keys_str_mv | AT gohringernils untersuchungenzurantineoplastischenwirkungneuartigerhdacinhibitorenbeiprostataundhepatozellularenkarzinomenstudiesontheantineoplasticeffectofnovelhdacinhibitorsinprostateandhepatocellularcarcinomas AT gohringernils studiesontheantineoplasticeffectofnovelhdacinhibitorsinprostateandhepatocellularcarcinomas |